A carregar...
Mesothelin as a biomarker for targeted therapy
CAR-T cell therapy targeting CD19 has achieved remarkable success in the treatment of B cell malignancies, while various solid malignancies are still refractory for lack of suitable target. In recent years, a large number of studies have sought to find suitable targets with low “on target, off tumor...
Na minha lista:
| Publicado no: | Biomark Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708176/ https://ncbi.nlm.nih.gov/pubmed/31463062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-019-0169-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|